Multi-compartmental vaccine delivery system for enhanced immune response to gp100 peptide antigen in melanoma immunotherapy

Pharmaceutical Research
Mayurkumar KalariyaMansoor Amiji

Abstract

To develop a multi-compartmental vaccine delivery system for safe and efficient delivery of the gp100 peptide antigen in melanoma immunotherapy. Water-in-oil-in-water (W/O/W) multiple emulsion-based multi-compartmental vaccine delivery system containing the gp100 peptide was prepared by a two-step emulsification method. In vivo prophylactic and active immunization effectiveness of the novel squalane oil-containing gp100 vaccine was evaluated in the murine B16 melanoma model and compared with that of an incomplete Freund's adjuvant (IFA)-based vaccine. Morphological evaluation of the W/O/W multiple emulsions showed that the oil-droplets were homogenously dispersed with the gp100 peptide encapsulated in an inner aqueous phase. Immunization with the gp100 peptide delivered in the W/O/W multiple emulsions-based vaccine resulted in increased protection against tumor challenge compared to IFA-based vaccine (p < 0.05, n = 8) signifying induction of enhanced anti-tumor immunity. In addition, serum Th1 cytokine levels and immuno-histochemistry of excised tumor tissues indicated activation and local infiltration of antigen specific cytotoxic T-lymphocytes into and/or surrounding the tumor mass. Moreover, the newly developed vaccine formu...Continue Reading

References

Jun 25, 1998·Cellular Immunology·M DupuisD M McDonald
Dec 22, 1998·The Journal of Experimental Medicine·S A Kalams, B D Walker
Sep 9, 1999·The Journal of Infectious Diseases·R F PassR L Burke
Oct 20, 1999·Methods : a Companion to Methods in Enzymology·A C Allison
Apr 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·R XiangR A Reisfeld
Dec 6, 2000·Advanced Drug Delivery Reviews·H Okochi, M Nakano
Feb 4, 2003·Nature Reviews. Immunology·Giorgio Trinchieri
Aug 20, 2003·The Journal of Experimental Medicine·Willem W OverwijkNicholas P Restifo
Jan 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hidetake MatsuyoshiYasuharu Nishimura
Mar 23, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sixun Yang, Frank G Haluska
Sep 2, 2004·Nature Medicine·Steven A RosenbergNicholas P Restifo
Mar 5, 2005·Trends in Immunology·Luis GracaHerman Waldmann
Aug 24, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yujun HuangLiang Qiao
Sep 15, 2005·Rheumatology·S L Peng
Nov 4, 2005·Cancer Research·Friedrich H Schmitz-WinnenthalPhilipp Beckhove
Jun 6, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Andrew G SikoraWillem W Overwijk
Jun 11, 2009·Drug Discovery Today·Derek T O'Hagan, Ennio De Gregorio
May 22, 2010·Seminars in Immunology·Thomas W Dubensky, Steven G Reed

Citations

Jan 1, 2014·Vaccines·Weidang LiAshlesh K Murthy
Dec 30, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Qin ZengXun Sun
May 26, 2017·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Husain AttarwalaMansoor Amiji
Jul 28, 2019·Biopreservation and Biobanking·Ewa DluskaBarbara Tudek

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.